Breaks Categories: News

TuesdayDec 20, 2022 12:01 pm

CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Files Updated Life Sciences Presentation

India Globalization Capital (NYSE American: IGC) today announced the filing of a life sciences presentation with the SEC on Form 8K. The presentation, available on the SEC website as well as published to IGC’s website, provides an overview of the company’s initiatives in life sciences. These include IGC’s focus on low-dose THC-based drug formulation and disease treatment and its various lines of cannabinoid-based consumer products. To view the full press release, visit https://cnw.fm/quvdW About India Globalization Capital Inc. India Globalization Capital, through its subsidiary IGC Pharma LLC, develops advanced cannabinoid-based formulations for treating diseases, including but not limited to Alzheimer’s,…

Continue Reading

FridayDec 16, 2022 10:26 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Shares Annual General Meeting Results

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting on the results of its 2022 annual meeting. The meeting of shareholders was held Dec. 15, 2022. During the meeting, shareholders considered and voted on all matters outlined in InMed’s notice of meeting and management information circular. Specifically, the election of directors was held, and shareholders approved the election of all director nominees to hold office until the next annual meeting of shareholders. Those directors included Eric Adams, Andrew Hull, Janet Grove, Bryan Baldasare, and Nicole Lemerond. To view…

Continue Reading

WednesdayDec 14, 2022 1:09 pm

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) Positioned in Rapidly Growing Market Estimated to Hit $172B in 2027

Advanced Container Technologies (OTC: ACTX) offers unique controlled environment farms called GrowPods. The company today announced a new report from KD Market Insights indicating that the market for controlled environment agriculture (“CEA”) is estimated to increase at a compound annual growth rate (“CAGR”) of 18.7% to reach $172 billion in 2027. The growth was attributed, in part, to an increase in world population, loss of agricultural land, as well as a strong demand for local foods. The report notes “remarkable advantages of CEA,” that include faster plant growth throughout the year, which allows for larger yields. “In a controlled environment,…

Continue Reading

TuesdayDec 13, 2022 10:30 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Appoints Interim Chief Financial Officer, Changes Auditor

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, announced that Jonathan Tegge, a member of Brio Financial Group, will shoulder the role of interim CFO effective Dec. 12, 2022. The announcement accompanied the news that InMed has signed a service contract with Brio Financial Group to provide senior financial leadership and bookkeeping services. A financial and management consulting group based in New Jersey, Brio outsources financial management and financial reporting support to small- and middle-market entities. Currently, the Brio team provides consulting services to some 50 private and publicly traded…

Continue Reading

MondayDec 12, 2022 11:45 am

CannabisNewsBreaks – ECGI Holdings Inc. (ECGI) Issues Update on Strategic Vision

ECGI Holdings (OTC: ECGI), D/B/A Elite Cannabis Group Incorporated, a Nevada-based portfolio company pivoting into the legal cannabis and cannabinoid marketplace, today provided an update to current and prospective shareholders. According to the update, the company is targeting a leadership role in product manufacturing and wholesale distribution in the legal cannabis marketplace in California. The company believes it has a built-in edge in targeting this niche, which offers a value proposition to small and medium sized grow operations and retailers. “The industry has effectively over-verticalized and there’s rampant inefficiency that drives value destruction for smaller producers and for the whole…

Continue Reading

FridayDec 09, 2022 12:04 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces $5M Registered Direct Offering

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced its entry into securities agreements with institutional investors for the purchase and sale of 12,500,000 of the company’s common shares, pursuant to a registered direct offering, and warrants to purchase up to 12,500,000 common shares. According to the update, the combined purchase price for one common share and one warrant will be $0.40. Aggregate proceeds from the offering will be approximately $5.0 million, from which the company expects to use net proceeds for capital expenditures, to increase operating capacity, as well as…

Continue Reading

WednesdayDec 07, 2022 12:54 pm

CannabisNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) GrowPods Return Local Control, Improve Food Quality

Advanced Container Technologies (OTC: ACTX) offers unique controlled environment farms called GrowPods, which can help reduce the environmental impact of traditional farming and enable year-round cultivation of nutritious food. According to a report republished in Science Direct, “hydroponic closed-environment agriculture could play a role in positive food system transformation, reducing environmental footprints, sparing land, and potentially helping to reconnect consumers with producers.” Further, according to Forbes, large volumes of greens are being grown indoors, even from retail giants, and controlled environmental agriculture is catching on and increasing in popularity. Doug Heldoorn, CEO of ACTX, said GrowPods are transportable and scalable,…

Continue Reading

WednesdayDec 07, 2022 12:01 pm

CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Applauds Milestone Development for Medical Cannabis Industry

India Globalization Capital (NYSE American: IGC) applauds the signing of the Medical Marijuana and Cannabidiol Research Expansion Act, which was signed into law by President Biden on Friday Dec. 2, 2022. The legislation establishes a new registration process for conducting research on marijuana and for manufacturing marijuana products for research purposes and drug development. “The study and development of cannabis for its potential therapeutic benefits is at the center of our work at IGC-Pharma,” said Ram Mukunda, CEO of IGC. “For many years, onerous federal barriers have made it difficult to efficiently source and study cannabis for pharmaceutical applications. We…

Continue Reading

FridayDec 02, 2022 10:50 am

CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Commences Trial Evaluating IGC-AD1 for the Treatment of Alzheimer’s-Related Symptoms

India Globalization Capital (NYSE American: IGC) announced that it has begun “A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Trial of the Safety and Efficacy of IGC-AD1 on Agitation in Participants with Dementia due to Alzheimer’s Disease.” According to the announcement, the company has commenced the phase 2 study at two U.S. sites and plans to add between three to five additional sites in the United States, Canada and possibly South America. “We believe that IGC-AD1 has the potential to revolutionize the treatment of Alzheimer’s Disease as the first and only low-dose natural THC-based formulation candidate currently undergoing FDA trials,” said…

Continue Reading

ThursdayDec 01, 2022 10:58 am

CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) to Present at RHK 2022 Disruptive Growth Conference

India Globalization Capital (NYSE American: IGC) has announced that its Chief Executive Officer Ram Mukunda will be presenting at the RHK Disruptive Growth Conference in New York City. Mukunda is slated to present beginning at 11:20 a.m. ET on Monday, Dec. 5, and will also be available for one-on-one meetings on Monday, Dec. 5 and Tuesday, Dec. 6. To view the full press release, visit https://cnw.fm/MZzYM About India Globalization Capital Inc. India Globalization Capital develops advanced cannabinoid-based formulations for treating diseases, including but not limited to Alzheimer’s, Parkinson’s, chronic pain, and pet seizures. The company’s leading drug candidate, IGC-AD1, has…

Continue Reading